Alexandr Shabliy, a competitor in the Professional Fighters League, has been handed a six-month suspension by the USADA due to a positive drug test for recombinant erythropoietin (rEPO). This synthetic hormone boosts red blood cell production, enhancing performance. Shabliy's suspension is retroactive to his test date of March 19, allowing him to return by September 19. Previously, he had been set to compete against Brent Primus in the PFL lightweight tournament, following a recent defeat that ended his nine-fight win streak against Usman Nurmagomedov.
Professional Fighters League lightweight Alexandr Shabliy has accepted a six-month suspension for a failed drug test, U.S. Anti-Doping Agency (USADA) announced. He tested positive for recombinant erythropoietin (rEPO) in an out-of-competition sample.
EPO is a synthetic hormone that increases the body's production of red blood cells, enhancing oxygen transport and aerobic power. Its use led to a previously known suspension of UFC champion T.J. Dillashaw.
Shabliy's suspension is retroactive to the date of his positive test on March 19, making him eligible to return to action on September 19.
The 32-year-old fighter, known as 'Peresvet,' was initially scheduled to compete against Brent Primus in the PFL lightweight tournament prior to the suspension.
Collection
[
|
...
]